Full name
LEK-PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Dispensing chemist in specialised stores
41.10.Z - Realization of building projects related to erection of buildings
41.20.Z - Building works related to erection of residential and non-residential buildings
46.46.Z - Wholesale of pharmaceutical goods
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
70.2 - Management consultancy activities
73.1 - Advertising
73.11.Z - Advertising agencies activities
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,5 | 2,3 | 2,2 | -5,6 |
Gross profit (loss) | 0,8 | 2,3 | 2,3 | 0 |
EBITDA | 0,8 | 2,3 | 2,1 | -6,2 |
Short time liabilities | 4,6 | 5,1 | 5,3 | 4,4 |
Other operating costs | 0,4 | 0,1 | 0,1 | -8,9 |
Equity capital | 2,1 | 2,1 | 2,6 | 25,6 |
Operating profit (EBIT) | 0,8 | 2,3 | 2,1 | -6,2 |
Assets | 6,7 | 7,1 | 7,9 | 10,6 |
Net profit (loss) | 0,7 | 2,3 | 2,2 | -5,7 |
Cash | 1,8 | 1,8 | 1,6 | -12,1 |
Net income from sale | 34,9 | 32,4 | 38,9 | 20,2 |
Liabilities and provisions for liabilities | 4,6 | 5,1 | 5,3 | 4,4 |
Working assets | 6,8 | 7,1 | 7,9 | 10,7 |
Other income costs | 0,7 | 0 | 0 | -50,9 |
Depreciation | 0 | 0 | 0 | -0,8 |
% | % | % | p.p. | |
Profitability of capital | 35,4 | 110,9 | 83,2 | -27,7 |
Equity capital to total assets | 31,4 | 29,2 | 33,2 | 4 |
Gross profit margin | 2,4 | 7,1 | 5,9 | -1,2 |
EBITDA Margin | 2,3 | 7 | 5,5 | -1,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 48 | 57 | 50 | -7 |
Current financial liquidity indicator | 1.4817715883255005 | 1.4087551832199097 | 1.494459629058838 | 0,1 |
Net dept to EBITDA | -2.2069783210754395 | 3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane